Article Information
History
- October 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Institute of Natural Sciences and School of Mathematics, Shanghai Jiao Tong University, Shanghai, China
- 2Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, USA
- 3Ruijin hospital proton therapy center Shanghai Jiaotong University School of Medicine
- 4Mevion Medical Systems, Inc., Kunshan, Jiangsu, China
- ↵†Corresponding Author Name & Email Address:
Min Tang, tangmin{at}sjtu.edu.cn
↵* These authors contributed equally to this work and should be considered co-first authors.